Timothy Rolph

Chief Scientific Officer

Timothy Rolph (Chief Scientific Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in AKRO. The largest single filing was $527K of AKRO (11,463 sh × $46.01, as filed), executed Oct 7 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 1 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$527K

shares × price, as filed

Last traded

Oct 7 2025

Filed Oct 9 2025

Open performance→

Volume by month

Buys $0 Sells $8.8M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Not on file 1 filing

Sector per market data · by filing · past 12 months

Most traded names

AKRO AKRO AKRO · 0 buys · 13 sells 13 filings

Recent filings

AKROSALE Akero Therapeutics, Inc. View filing → $527K
11,463 sh × $46.01
Exec Oct 7 2025
Filed Oct 9 2025 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. View filing → $551K
12,466 sh × $44.17
Exec Sep 8 2025
Filed Sep 10 2025 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. View filing → $616K
12,500 sh across 2 lots
Exec Aug 5 2025
Filed Aug 7 2025 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. View filing → $542K
10,634 sh × $50.93
Exec Jul 7 2025
Filed Jul 9 2025 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. View filing → $127K
2,358 sh × $54.00
Exec Jun 10 2025
Filed Jun 12 2025 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. View filing → $2.0M
37,500 sh across 3 lots
Exec Jun 5 2025
Filed Jun 9 2025 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. View filing → $529K
12,200 sh across 2 lots
Exec May 6 2025
Filed May 8 2025 · 5:30 PM ET AKROSALE Akero Therapeutics, Inc. View filing → $256K
6,250 sh × $41.03
Exec Apr 24 2025
Filed Apr 28 2025 · 5:30 PM ET More filings →